RE:RE:RE:RE:Does xB3 Work?I've already answered that, TT, many, many times.
Why would you expect any company with integrity to do a deal with a company like Bioasis that is engaged in the type of things that Rathjen was doing with Bioasis and with Ladenberg Thalmann?
Rathjen, by downplaying xB3 and camouflaging it with the Cresence stuff, was signalling that xB3 was either weak or no good. Most informed people (except you, it seems) would realize that Rathjen didn't want the share price to go up.
She accidently released a document saying that there was a deal with Ellipses. Were Rathjen and LT and The Gang interested in that deal? I doubt it. It would drive up the value of Bioasis and xB3, and that was not in the interests of Rathjen and LT and The Gang.
Did Chiesi bail because they couldn't make a fusion protein with xB3, as hinted? If so, did that have anything to do with ProCellEx's capabilities, or the capabilities of the Protalix people? Or did Chiesi, in a fit of indignation, decide they didn't want to be involved in the goings-on with Rathjen and LT and The Gang?
Were their any other companies that passed on Bioasis becaue they were uncomfortable with the play being orchestrated against Bioasis shareholders.
And finally, LT, Midatech, Armistice, Rathjen and Saltarelli all wanted Bioasis to be put into Biodexa's hands. They spent two years and huge legal expenses to get it done. They orchestrated Armistice control of Midatech/Biodexa through the prepaid warrants. Why? Without xB3 Bioasis is essentially worthless, by Midatech's own documentation. Look at the value they placed on EGF.
The pharmas that were dealing with Bioasis, or thinking about it, may very well have been concerned by the assault being put on Bioasis and Midatech shareholders. They may also have understood that the future ownership of xB3 was very uncertain, at best, or that xB3 was going to end up in the hands of a group that orchestrated the buyout.
As a result, I think it possible that Bioasis partners and potential partners realized that Bioasis was going down, either by incompetence or malice, and, either way, they were not interested in being partners with such a group.
I don't think it had anything to do with xB3. xB3 has always worked. More to the point, Midatech, LT, Armistice, DrDR and Mario all wanted the deal. Without xB3 there was no point to a deal.
So no, whatever partners and potential partners had dropped out, I doubt they did so because of xB3's capabilities.
And note, also, that Midatech, in their filings about the deal, talked about the few small xB3 drugs they would get and the smaller partnerships they would inherit. But nowhere did they talk about having and using the xB3 Platform, nor, very tellingly, did they promote acquisitions of xB3-001, xB3-004 nor any of the other major xB3 projects. That, in my opinion, is because they weren't going to get them. They would go to the private company, to The Chosen Corp.
I could have some of the details wrong but one thing for almost certain, xB3 works and the gang was trying to get control of it. I still think that will happen in the next few weeks or sooner.
I don't care what you or anybody else thinks about my, TT. I just want it on the record. We'll know soon.
So, you haven't answered my question, TT. Are you being paid to influence the arguments? To plant doubt about me? Doesn't matter to me. Rathjen will issue a public answer very soon. It's likely that Bioasis and/or xB3 will be sold and that Rathjen and Saltarelli will also be sold with xB3 to the new owners.
Having fun, TT? (You forgot to mention bankruptcy a couple of times today. Get back on topic, buddy!)
Bwah hahahaha!
jd